Rejection of tumors of the B cell lineage by idiotype-vaccinated mice

Cancer Immunology Immunotherapy

Volumn 47, Issue 6, 1999, Pages 330-336

  Haimovich, Joseph ^a   Kukulansky, Tova ^a   Weissman, Bela ^a   Hollander, Nurit ^a  

^a TEL AVIV UNIVERSITY   (Israel)

Author keywords

Anti idiotype antibodies; B cell lymphoma; Cell mediated immunity; Immunotherapy; Plasmacytoma

Indexed keywords

CANCER VACCINE; IMMUNOGLOBULIN; TUMOR ANTIGEN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN PRESENTATION; ARTICLE; B CELL LYMPHOMA; CANCER CELL CULTURE; CANCER IMMUNOTHERAPY; CELL SURFACE; CELLULAR IMMUNITY; CONTROLLED STUDY; HUMORAL IMMUNITY; IMMUNIZATION; MOUSE; NONHUMAN; PLASMA CELL; PRIORITY JOURNAL; TUMOR REJECTION; TUMOR RESISTANCE;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; ANTIBODIES, ANTI-IDIOTYPIC; CANCER VACCINES; CELL LINEAGE; HEMOCYANIN; IMMUNITY, CELLULAR; IMMUNOCONJUGATES; IMMUNOGLOBULIN IDIOTYPES; IMMUNOGLOBULIN M; LYMPHOMA, B-CELL; MICE; MICE, INBRED BALB C; MICE, INBRED C3H; PLASMACYTOMA;

EID: 0032997218     PISSN: 03407004     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002620050538     Document Type: Article

References (44)

1. Bergman Y, Haimovich J (1977) Characterization of a carcinogen-induced murine B lymphocyte cell line of C3H/eB origin. Eur J Immunol 7:413
2. Bergman Y, Haimovich J (1978) B-lymphocytes contain three species of μ chains. Eur J Immunol 8:876
3. Bogen B, Hannestad K (1984) Specificity of antibody and helper T-cell responses to the isologous myeloma protein W3129 and its subunits. Mol Immunol 21:653
4. Bogen B, Mallisen B, Haas W (1986) Idiotype-specific T cell clones that recognize syngeneic immunoglobulin fragments in the context of class II molecules. Eur J Immunol 16:1373
5. Campbell MJ, Carroll W, Kon S, Thielemans K, Rothbard JB, Levy S, Levy R (1987) Idiotype vaccination against murine B cell lymphoma. Humoral and cellular responses elicited by tumor-derived immunoglobulin M and its molecular subunits. J Immunol 139:2825
6. Campbell MJ, Esserman L, Byars NE, Allison AC, Levy R (1990) Idiotype vaccination against murine B cell lymphoma. Humoral and cellular requirements for the full expression of antitumor immunity. J Immunol 145:1029
7. Caspi Y, Taya M, Hollander N, Haimovich J (1995) Light chain loss and reexpression leads to idiotype switch. Surrogate light chains are probably responsible for this process. Cur Topics Microbiol Immunol 194:179
8. Cleary ML, Meeker TC, Levy S, Lee E, Trela M, Sklar J, Levy R (1986) Clustering of extensive somatic mutation in the variable region of an immunoglobulin heavy chain gene from a human B cell lymphoma. Cell 44:97
9. Daley MJ, Gebel HM, Lynch RG (1978) Idiotype-specific transplantation resistance to MOPC-315: abrogation by post-immunization thymectomy. J Immunol 120:1620
10. Eshhar Z, Blatt C, Bergman Y, Haimovich J (1979) Induction of secretion of IgM from cells of the B cell line 38C13 by somatic cell hybridization. J Immunol 122:2430
11. 1. J Immunol 138:628
12. George AJT, Folkward SG, Hamblin TJ, Stevenson FK (1988) Idiotypic vaccination as a treatment for a B cell lymphoma. J Immunol 141:2168
13. 1, with different growth characteristics. J Immunol 140:1695
14. Hombach J, Stablitzky F, Rajewsky K, Reth M (1988) Transfected plasmacytoma cells do not transport the membrane form of IgM to the cell membrane. J Exp Med 167:652
15. Hsu FJ, Casper CB, Czerwinski D, Kwak LW, Liles TM, Syrengelas A, Taidi-Laskowski B, Levy R (1997) Tumor-specific idiotype vaccines in the treatment of patients with B-cell lymphoma. Long term results of a clinical trial. Blood 89:3129
16. Jorgensen T, Gaudernack G, Hannestad K (1977) Production of BALB/c anti-idiotypic antibodies against the BALB/c myeloma protein 315 does not require an intact ligand-binding site. Scand J Immunol 6:311
17. King CA, Wills MR, Hamblin TJ, Stevenson FK (1993) Idiotypic IgM on a B-cell surface requires processing for recognition by anti-idiotypic T cells. Cell Immunol 147:411
18. Kranz DM, Voss EW Jr (1983) Idiotypic analysis of monoclonal anti-fluorescyl antibodies; localization and characterization of idiotypic determinants. Mol Immunol 20:1301
19. 1 a murine model for chronic lymphocytic leukemia: use of the surface immunoglobulin idiotype for the detection and treatment of tumors. Immunol Rev 48:81
20. Kwak LW, Campbell MJ, Czerwinski DK, Hart S, Miller RA, Levy R (1992) Induction of immune responses in patients with B-cell lymphoma against the surface-immunoglobulin idiotype expressed by their tumors. N Engl J Med 327:1209
21. Lamon EW, Whitten HD, Skurzak HM, Andersson B, Lidin B (1975) IgM antibody-dependent cell-mediated cytotoxicity in the Moloney sarcoma virus system: the involvement of T and B lymphocytes as effector cells. J Immunol 115:1288
22. Lamon EW, Shaw MW, Goodson S, Lidin B, Walia AS, Fuson EW (1977) Antibody-dependent cell-mediated cytotoxicity in the Moloney sarcoma virus system: different activity of IgG and IgM with different subpopulations of lymphocytes. J Exp Med 145:302
23. Lanier L, Babcock G, Raybourne R, Arnold L, Warner N, Haughton G (1980) Mechanism of B cell lymphoma immunotherapy with passive xenogeneic antiidiotype serum. J Immunol 125:1730
24. +T cells in tumor resistance against major histocompatibility complex class II molecule negative plasmacytoma cells. Cell Immunol 148:177
25. Levy S, Campbell MJ, Levy R (1989) Functional immunoglobulin light chain genes are replaced by ongoing rearrangement of germline Vκ genes to downstream Jκ segments in a murine B cell line. J Exp Med 170:1
26. Loh DY, Bothwell AL, White-Scharf ME, Imanishi-Kari T, Baltimore D (1983) Molecular basis of a mouse strain-specific anti-hapten response. Cell 33:85
27. Lynch RG, Graff RJ, Sirisinha S, Simms ES, Eisen HN (1972) Myeloma proteins as tumor-specific transplantation antigens. Proc Natl Acad Sci USA 69:1540
28. Maloney DG, Kaminski MS, Burowski D, Haimovich J, Levy R (1985) Monoclonal anti-idiotype antibodies against the murine B cell lymphoma 38C13: characterization and use as probes for the biology of the tumor in vivo and in vitro. Hybridoma 4:191
29. Meeker TC, Lowder J, Cleary ML, Stewart S, Warnke R, Sklar J, Levy R (1985) Emergence of idiotype variants during treatment of B-cell lymphoma with anti-idiotype antibodies. N Engl J Med 312:1658
30. Meeker TC, Lowder J, Maloney DG, Miller RA, Thielemans K, Warnke R, Levy R (1985) A clinical trial of anti-idiotype therapy for B cell malignancy. Blood 65:1349
31. Odermatt BF, Perlmutter R, Lynch RG (1978) Molecular heterogeneity and fine specificity of BALB/c antibodies elicited by isologous myeloma protein. Eur J Immunol 8:858
32. Oi VT, Morrison S, Herzenberg LA, Berg P (1983) Immunoglobulin gene expression in transformed lymphoid cells. Proc Natl Acad Sci USA 80:825
33. 2 fragments against idiotypic determinants of its cell surface IgM. J Immunol 131:1600
34. Peto R, Pike MC, Armitage P, Breslow NE, Cox DR, Howard SV, Mantel N, McPherson K, Peto J, Smith PG (1977) Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. Analysis and examples, Br J Cancer 35:1
35. Rimm IJ, Schlossman SF, Reinherz EL (1981) Antibody-dependent cellular cytotoxicity and natural-killer-like activity are mediated by subsets of activated T cells. Clin Immunol Immunopathol 21:134
36. Roland J, Cazenave PA (1981) Rabbits immunized against B6 allotype express similar anti-B6 idiotopes. Eur J Immunol 11:469
37. Sirisinha S, Eisen HN (1971) Autoimmune-like antibodies to the ligand-binding sites of myeloma proteins. Proc. Natl Acad Sci USA 68:3130
38. Sitia R, Neuberger M, Milstein C (1987) Regulation of membrane IgM expression in secretory B cells: translational and post-translational events. EMBO J 6:3969
39. Starnes CO, Carrol WL, Campbell MJ, Houston LL, Apell G, Levy R (1988) Heterogeneity of a murine B cell lymphoma. J Immunol 141:333
40. Stevenson GT, Glennie MJ (1985) Surface immunoglobulin of B-lymphocytes as a therapeutic target. Cancer Surv 4:213
41. Suzan M, Boyer C, Schiff C, Trucy J, Milili M, de Preval C (1982) Monoclonal antibodies reveal three types of idiotypic determinants on MOPC 173: H-L-specific private and public idiotopes and VH-specific public idiotopes(s). Mol Immunol 19:1051
42. Taya M, Haimovich J (1991) Immunotherapy of B lymphoma by anti-idiotype antibodies: characterization of variant tumor cells appearing a long time after the initial tumor inoculation. Cancer Immunol Immunother 34:43
43. Weiss S, Bogen B (1991) MHC class II-restricted presentation of intracellular antigen Cell 64:767
44. Zeldis JB, Konigsberg WH, Richards FF, Rosenstein RW (1979) The location and expression of idiotypic determinants in the immunoglobulin variable region. II. Chain location of variable region determinants. Mol Immunol 16:371